CHICAGO - At Northwestern, surgeons are able to not only save a Chicago cartoonist's life but her fertility as well. Iona Woolmington was just 35 years old when she was diagnosed with stage three ...

Johnson & Johnson has signaled that it will attempt to disqualify certain plaintiffs' lawyers and use other aggressive ...

Mirvetuximab soravtansine improved overall survival, progression-free survival, second progression-free survival, and other outcomes.

A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of ...

A new study has identified the protein ADAMTS5 as playing a crucial role in the spread of ovarian cancer cells, offering a ...

A new drug combination from Corcept Therapeutics, relacorilant, has shown potential in treating platinum-resistant ovarian ...

Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.

Corcept Therapeutics (CORT) stock shot up over 100% yesterday as markets reacted to the company’s announcement of promising outcomes from its ...

Single-cell characterization of healthy fallopian tubes revealed shifts in cell and gene expression throughout the menstrual ...

Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis.

A U.S. bankruptcy judge has denied Johnson & Johnson's settlement plan relating to its baby powder products containing talc.

Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the ...